Note: Descriptions are shown in the official language in which they were submitted.
CA 02945794 2016-10-13
WO 2015/161177 PCT/US2015/026338
- 1 -
SYSTEMS AND METHODS FOR DROPLET TAGGING
RELATED APPLICATIONS
This application claims the benefit of U.S. Provisional Patent Application
Serial
No. 61/981,123, filed April 17, 2014, entitled "Systems and Methods for
Droplet
Tagging," by Bernstein, et al., incorporated herein by reference.
GOVERNMENT FUNDING
This invention was made with government support under Grant No.
P01GM096971 awarded by the National Institutes of Health, and under Grant Nos.
DMR-1006546 and DMR-0820484 awarded by the National Science Foundation. The
government has certain rights in the invention.
FIELD
The present invention generally relates to microfluidic devices, including
systems
and methods for tagging droplets within such devices.
BACKGROUND
A variety of techniques exist for producing fluidic droplets within a
microfluidic
system, such as those disclosed in Int. Pat. Pub. Nos. WO 2004/091763, WO
2004/002627, WO 2006/096571, WO 2005/021151, WO 2010/033200, and WO
2011/056546, each incorporated herein by reference in its entirety. In some
cases,
relatively large numbers of droplets may be produced, and often at relatively
high
speeds, e.g., the droplets may be produced at rates of least about 10 droplets
per second.
The droplets may also contain a variety of species therein. However, it can be
difficult
to accurately track such droplets, especially when large numbers of droplets
are produced
and/or the droplets are produced at very high rates. In addition, such
tracking may be
complicated if the droplets are exposed to a variety of different conditions,
contain
different species, etc., such that the droplets are not all identical.
SUMMARY
The present invention generally relates to microfluidic devices, including
systems
and methods for tagging droplets within such devices. The subject matter of
the present
invention involves, in some cases, interrelated products, alternative
solutions to a
particular problem, and/or a plurality of different uses of one or more
systems and/or
articles.
CA 02945794 2016-10-13
WO 2015/161177 PCT/US2015/026338
- 2 -
In one aspect, the present invention is generally directed to a method,
According
to one set of embodiments, the method comprises exposing a droplet to a first
condition
and adding a first nucleic acid to the droplet, wherein the first nucleic acid
encodes the
first condition; exposing the droplet to a second condition and adding a
second nucleic
acid to the droplet, wherein the second nucleic acid encodes the second
condition; and
ligating the first nucleic acid and the second nucleic acid together.
The method, in accordance with another set of embodiments, includes can act of
exposing a plurality of droplets to a plurality of conditions such that
substantially each
droplet is sequentially exposed to at least two different conditions, wherein
when a
droplet is exposed to a condition, a nucleic acid encoding the condition is
added to the
droplet.
In yet another set of embodiments, the method includes acts of exposing a cell
contained within a droplet to a first species, and adding a first nucleic acid
to the droplet,
exposing the cell to a second species, and adding a second nucleic acid to the
droplet,
ligating the first nucleic acid and the second nucleic acid together,
determining a
property of the cell, and sorting the droplet based on the property of the
cell.
Still another set of embodiments is generally directed to a method comprising
an
act of encapsulating a plurality of cell types and a plurality of nucleic
acids in a plurality
of droplets such that substantially each droplet comprises one or more cells
of only one
cell type and an encoding nucleic acid encoding the only one cell type.
The method, in one set of embodiments, includes acts of providing a plurality
of
cell types and a plurality of nucleic acids in a plurality of droplets such
that substantially
each droplet comprises one or more cells of only one cell type and an encoding
nucleic
acid encoding the only one cell type, lysing the cells within the droplets to
release
cellular nucleic acid from the cells, ligating the encoding nucleic acid and
the cellular
nucleic acid together, and sequencing the ligated nucleic acids.
In another set of embodiments, the method includes acts of providing a
plurality
of cell types and a plurality of nucleic acids in a plurality of droplets such
that
substantially each droplet comprises one or more cells of only one cell type
and an
encoding nucleic acid encoding the only one cell type; exposing the plurality
of droplets
to a plurality of species such that substantially each droplet is exposed to a
single species
of the plurality of species, and adding a first nucleic acid encoding the
single species
CA 02945794 2016-10-13
WO 2015/161177
PCT/US2015/026338
-3 -
thereto; lysing the cells within the droplets to release cellular nucleic acid
from the cells;
ligating the encoding nucleic acid, the first nucleic acid, and the cellular
nucleic acid
together; and sequencing the ligated nucleic acids.
In another aspect, the present invention is generally directed to a plurality
of
droplets. In some cases, at least some of the droplets contain nucleic acids
encoding a
plurality of conditions that the at least some droplets were exposed to.
The present invention, in accordance with another aspect, is generally
directed to
a library of droplets containing a plurality of cell types and a plurality of
nucleic acids.
In some embodiments, substantially each of the cell types is encoded by a
unique nucleic
acid sequence.
In another aspect, the present invention encompasses methods of making one or
more of the embodiments described herein. In still another aspect, the present
invention
encompasses methods of using one or more of the embodiments described herein.
Other advantages and novel features of the present invention will become
apparent from the following detailed description of various non-limiting
embodiments of
the invention when considered in conjunction with the accompanying figures. In
cases
where the present specification and a document incorporated by reference
include
conflicting and/or inconsistent disclosure, the present specification shall
control. If two
or more documents incorporated by reference include conflicting and/or
inconsistent
disclosure with respect to each other, then the document having the later
effective date
shall control.
BRIEF DESCRIPTION OF THE DRAWINGS
Non-limiting embodiments of the present invention will be described by way of
example with reference to the accompanying figures, which are schematic and
are not
intended to be drawn to scale. In the figures, each identical or nearly
identical
component illustrated is typically represented by a single numeral. For
purposes of
clarity, not every component is labeled in every figure, nor is every
component of each
embodiment of the invention shown where illustration is not necessary to allow
those of
ordinary skill in the art to understand the invention. In the figures:
Figs. 1A-1C schematically illustrate various methods for tagging droplets, in
accordance with various embodiments of the invention; and
CA 02945794 2016-10-13
WO 2015/161177 PCT/US2015/026338
- 4 -
Figs. 2A-2B schematically illustrates joining together various nucleic acid
tags,
in certain embodiments of the invention.
DETAILED DESCRIPTION
The present invention generally relates to microfluidic devices, including
systems
and methods for tagging droplets within such devices. In some aspects,
microfluidic
droplets are manipulated by exposing the droplets (or other entities) to a
variety of
different conditions. By incorporating a plurality of "tags," e.g., nucleic
acid tags, into
the droplets and joining the tags together, the conditions that a droplet was
exposed to
may be encoded. Thus, even if droplets exposed to different conditions are
mixed
together, the conditions that each droplet encountered may still be
determined, for
example, by sequencing the nucleic acids.
Initially, certain non-limiting examples are discussed with reference to Fig.
1.
However, in other embodiments, other configurations may be used as well.
Turning first
to Fig. 1A, a droplet is shown that is exposed to a variety of conditions (for
example, a
species such as a drug), and each time the droplet is exposed to a condition,
a nucleic
acid encoding the condition is added to the droplet. It should be noted that
the condition
need not be the addition of a chemical species, but could also be a physical
condition,
such as exposure to a particular temperature. It should further be noted that
although
droplets are discussed with reference to Fig. 1, this is for ease of
presentation only; in
other embodiments, other discrete entities may be used instead of these
droplets, for
example, microwells in a microwell plate.
As is shown in this example, droplet 10 first encounters, and is fused with,
droplet 12 containing species X and nucleic acid 1. Subsequently, droplet 10
encounters
and is fused with droplet 13 (containing species Y and nucleic acid 2) and
droplet 14
(containing species Z and nucleic acid 3). An enzyme E may then be introduced
in some
fashion into droplet 10, for example, as part of another droplet fusion event
(as is shown
here with droplet 15), or the enzyme may initially be found in any one of
droplets 10, 12,
13, or 14. The enzyme may be used to ligate nucleic acids 1, 2, and 3
together, as is
shown with ligated nucleic acids 1-2-3. The droplet can then be burst to
access the
ligated nucleic acid, and the nucleic acid can be sequenced or otherwise
determined to
determine the history of droplet 10.
CA 02945794 2016-10-13
WO 2015/161177 PCT/US2015/026338
-5 -
In some embodiments, two or more droplets may be treated in such a fashion, as
is shown in Fig. 1B. For instance, two or more droplets may be exposed to a
variety of
different conditions, where each time a droplet is exposed to a condition, a
nucleic acid
encoding the condition is added to the droplet. However, even if such droplets
with
different histories are later combined (e.g., in a mixture), as is shown in
container 20, the
conditions each of the droplets was exposed to is still determinable through
the different
nucleic acids contained in each droplet. This is true even if the droplets
themselves are
burst and/or the contents are mixed together. For example, as is shown in Fig.
1B, by
determining nucleic acids 1-2-3, 4-5-6, and 7-8-9, one knows that at least one
droplet in
container 20 was exposed to conditions A, B, and C, at least one droplet was
exposed to
conditions I, J, and K, and at least one droplet was exposed to conditions X,
Y, and Z. In
addition, one may also be able to determine that no droplets in container 20
was exposed
to other sets of conditions. For example, one may be able to determine that no
droplet
was exposed to conditions X, Y, and K, as there is no sequence 1-2-9 present
in
container 20.
As is shown in Fig. 1C, in certain embodiments of the invention, testing
and/or
sorting of the droplets may also occur. As shown in this figure, a plurality
of droplets
exposed to different conditions (as encoded by the nucleic acids contained
therein,
represented by various numbers) may be sorted based on some criteria. For
example, if
the droplet further contain cells, then a property of the cell (e.g., whether
the cell is alive
or dead) may be used to sort the droplets into 2 (or more) populations. Each
population
can then be separately analyzed, e.g., by determining the nucleic acids
contained therein,
to determine which conditions may have led to the different populations. For
instance, in
Fig. 1C, a population of droplets 30 was sorted into a first group (A) and a
second group
(B). The nucleic acids in each group can then be sequenced. Thus, for example,
it may
be determined that the members of Group A each have conditions 2 and 3 in
common,
while the members of Group B do not have conditions 2 and 3 in common
(although
conditions 2 or 3 may be separately present in some of the Group B droplets).
Thus,
these sorting experiments would demonstrate that the combination of conditions
2 and 3
is necessary for some effect to occur (Group A), and if both are not present,
the effect
does not occur (Group B).
CA 02945794 2016-10-13
WO 2015/161177 PCT/US2015/026338
- 6 -
Also noteworthy is that in Fig. 1C, the number of conditions each droplet is
exposed to is not necessarily the same; instead, the conditions may vary,
i.e.,
intentionally, or due to experimental errors or uncertainty. For example,
droplet 2-4 was
exposed to conditions 2 and 4, while droplet 1-2-3-6 was exposed to conditions
1, 2, 3,
and 6. Furthermore, it should also be noted that, due to the ligation of the
nucleic acids
prior to removing the nucleic acids from the droplets, the conditions each
droplet was
exposed to may be separately maintained and analyzed, even if the droplets
and/or the
nucleic acids are subsequently mixed together. Thus, with reference to Fig.
1C, if the
nucleic acids were not ligated together, then each of Groups A and B would
appear to be
identical, since each group contains the same numbers (representing
conditions) in
exactly the same proportions in this illustrative example.
Thus, one surprising feature of certain embodiments of the invention is that
the
ligated nucleic acids allow more complex conditions to be readily determined,
for
example a single condition or multiple conditions. This can be accomplished
without
loss of information even if the droplets are burst or otherwise combined
together, e.g.,
for ease of processing or analysis. In contrast, in techniques in which
various tags are
separately introduced into droplets, without ligation or other methods of
combining the
tags together, the conditions cannot be so readily analyzed; instead, care
must be taken in
keeping each of the droplets separate, as any tags that are accidently
combined (for
example by bursting or fusing different droplets together) would result in
loss of
information.
The above discussion is not intended to be limiting; other embodiments of the
invention are also possible for tagging droplets, as will now be discussed.
For instance,
various aspects of the present invention are generally directed to systems and
methods
for tagging or identifying droplets within microfluidic devices, e.g., using
nucleic acids
and other "tags," that can be bound together. By binding the tags together,
information
about the droplet containing the tag may be retained, e.g., even after the tag
is separated
from the droplet and/or combined with other, different tags. Thus, for
example, a
plurality of tags from different droplets (e.g., exposed to different
conditions) may be
combined and analyzed together.
Certain aspects of the present invention involve the use of a plurality of
droplets
or other discrete entities, e.g., where the contents of the entities are not
readily mixed
CA 02945794 2016-10-13
WO 2015/161177 PCT/US2015/026338
- 7 -
with the contents of other entities. For example, the discrete entities may be
droplets
contained within a carrying fluid, microwells of a microwell plate, individual
spots on a
slide or other surface, or the like. As discussed herein, each of the entities
may a specific
location that can contain one or more tags or other species, without
accidental mixing
with other entities. The entities may be relatively small in some cases, for
example, each
entity may have a volume of less than about 1 ml, less than about 300
microliters, less
than about 100 microliters, less than about 30 microliters, less than about 10
microliters,
less than about 3 microliters, less than about 1 microliter, less than about
500 nl, less
than about 300 nl, less than about 100 nl, less than about 50 nl, less than
about 30 nl, or
less than about 10 nl.
In some embodiments, the droplet or other entity may contain various species,
e.g., cells, chemicals, or the like. Other examples of species are discussed
herein. For
example, if the droplet or other entity contains one or more cells, the cells
may be
substantially identical or different. For example, a droplet or other entity
may contain
more than one cell or other species), where the cells (or other species) are
the same or
different; the cells (or other species) in different droplets or entities may
also be the same
or different. If cells are used, the cells may also be, in some embodiments,
from a
specific population of cells, such as from a certain organ or tissue (e.g.,
cardiac cells,
immune cells, muscle cells, cancer cells, etc.), cells from a specific
individual or species
(e.g., human cells, mouse cells, bacteria, etc.), cells from different
organisms, cells from
a naturally-occurring sample (e.g., pond water, soil, etc.), or the like.
Thus, as non-limiting examples, the effects of one or more conditions on a
specific type of cell (or specific types of cells) may be studied. As another
example, the
effects of a certain specific condition (or conditions) on a suitable
population of cells
may be studied. It addition, it should be noted that the present invention is
not limited to
only study of cells. In other embodiments, for example, the droplets or other
entities
may contain species in which a variety of conditions is to be applied. For
example, the
species may be a chemical reagent, e.g., one that is biological or
nonbiological, organic
or inorganic, etc. For instance, the species may be a polymer, a nucleic acid,
a protein, a
drug, a small molecular compound (e.g., having a molecular weight of less than
about
1000 Da or less than about 2000 Da), an antibody, an enzyme, a peptide, or the
like.
Other examples of species are discussed in more detail below.
CA 02945794 2016-10-13
WO 2015/161177 PCT/US2015/026338
- 8 -
One or more tags may be present within a droplet (or other entity), which can
be
analyzed to determine the identity and/or history of the droplet. In some
cases, the tags
may be chosen to be relatively inert relative to other components of the
droplet or other
entity. The tags may be present initially in the droplet or other entity,
and/or
subsequently added, e.g., using processes such as those described below. For
instance,
tags may be added when the droplet or other entity is exposed to one or more
conditions
(or proximate in time to such exposure). In some cases, more than one tag may
be
present in a droplet or other entity.
In certain embodiments of the invention, the tags within a droplet or other
entity
can be joined together, for example, chemically, to produce a joined tag. Any
suitable
technique may be used to join tags together, e.g., prior to removal from the
droplet or
entity. The tags may be joined using any suitable technique. For example, the
tags may
be joined together using an enzyme, a catalyst, or a reactant, which may be
added to the
droplet or other entity using any suitable technique. For instance, a droplet
containing
the tags may be fused to another droplet containing the chemical agent, or a
chemical
reactant may be added or inserted into a droplet or other entity, for example,
using
pipetting or other techniques, and in some cases, using automated techniques.
By joining the tags in a droplet (or other entity) together to produce a
joined tag,
the identity and/or history of the droplet may be maintained by maintaining
the joined
tags, even if the tags are separated from the droplet or tags from different
droplets are
mixed together. For example, joined tags from a variety of droplets or
entities can be
collected together and analyzed. In some embodiments, a series of droplets or
other
entities may be separated into various groups depending on various properties,
and the
tags within each group may be manipulated together and/or used to identify
such droplets
or entities having such properties.
The tags may include, for example, nucleic acids, which may be joined together
or ligated using suitable enzymes able to ligate the nucleic acids together,
such as
ligases. Non-limiting examples of ligases include DNA ligases such as DNA
Ligase I,
DNA Ligase II, DNA Ligase III, DNA Ligase IV, T4 DNA ligase, T7 DNA ligase, T3
DNA Ligase, E. coli DNA Ligase, Taq DNA Ligase, or the like. Many such ligases
may
be purchased commercially. In addition, in some embodiments, two or more
nucleic
acids may be ligated together using annealing or a primer extension method.
CA 02945794 2016-10-13
WO 2015/161177 PCT/US2015/026338
- 9 -
As discussed herein, various sequences of nucleic acids can be used to encode
specific conditions that a droplet or other entity may be exposed to, and such
nucleic
acids can be added thereto to indicate such exposure to a condition, in
accordance with
certain embodiments. In some cases, the nucleic acids within a droplet or
other entity
may be ligated together prior to removal (for example, upon bursting of a
droplet,
washing of a slide, etc.). Different nucleic acids from different droplets or
entities may
be mixed together; however, even after such mixing, each nucleic acid can be
individually sequenced to determine the specific conditions that the
corresponding
droplet or entity had been exposed to.
Any suitable system may be used for encoding. For example, in one set of
embodiments, a nucleic acid tag may include an encoding region of nucleotides,
and
optionally a connecting region. The nucleotides in the encoding region may
correspond
to a specific condition (or set of conditions). Any suitable number of
conditions may be
arbitrarily encoded in such a fashion, where the number of conditions that are
encodable
by such an encoding region may be determined by the number of nucleotides in
the
encoding region. Thus, for instance, an encoding region having length n can
encode up
to 4' regions (based on the four types of nucleotides). For example, a first
condition may
be encoded with A, a second condition may be encoded with T (or U if the
nucleic acid
is an RNA), a third condition may be encoded with G, a fourth condition may be
encoded with C, etc. As a more complex example, an encoding region containing
3
nucleotides is sufficient to encode over 50 different conditions (since 43 =
64). One or
more than one encoding region may be used. In addition, the encoding region
may also
include other nucleotides used for error detection and/or correction,
redundancy, or the
like, in certain embodiments.
A nucleic acid tag may also include, in some cases, one or more connecting
regions, which are ligated together. For example, the connecting regions may
include
"sticky ends," or overhangs of nucleic acids, such that only specific nucleic
acids can be
properly ligated together. For instance, as is shown in Fig. 2A, a first
nucleic acid tag 21
(encoding a first condition) may include a first sticky end that is
substantially
complementary to a sticky end on second nucleic acid tag 22 but not to a
sticky end on
third nucleic acid tag 23; similarly, second nucleic acid 22 (encoding a
second condition)
may include a sticky end that is substantially complementary to a sticky end
on third
CA 02945794 2016-10-13
WO 2015/161177 PCT/US2015/026338
- 10 -
nucleic acid tag 23 (encoding a third condition) but not to the sticky end on
first nucleic
acid 21. Thus, upon exposure to suitable ligases, the first, second, and third
nucleic acids
may be joined or ligated together in an order suitable for subsequent study,
without the
nucleic acids being incorrectly ligated together in an incorrect order (e.g.,
a first nucleic
acid being ligated to another first nucleic acid). Accordingly, by sequencing
the final
ligated nucleic acid, it can be determined that this nucleic acid was in a
droplet or other
entity exposed to the first, second, and third conditions.
However, it should be understood that in other embodiments, there may be no
need to ensure that the nucleic acid tags are ligated together in a certain
configuration or
order. For example, as is shown in Fig. 2B, nucleic acids 21, 22, and 23 may
be ligated
together in any suitable order; and the resulting ligated nucleic acid may be
analyzed to
determine that that the nucleic acid encoded the conditions encoded by nucleic
acids 21,
22, and 23.
The nucleic acid tag may also have any suitable length or number of
nucleotides,
depending on the application. For example, a nucleic acid tag may have a
length shorter
or longer than 10 nt, 30 nt, 50 nt, 100 nt, 300 nt, 500 nt, 1000 nt, 3000 nt,
5000 nt, or
10000 nt, etc. In some cases, other portions of the nucleic acid tag may also
be used for
other purposes, e.g., in addition to encoding conditions. For example,
portions of the
nucleic acid tag may be used to increase the bulk of the nucleic acid tag
(e.g., using
specific sequences or nonsense sequences), to facilitate handling (for
example, a tag may
include a poly-A tail), to increase selectivity of binding (e.g., as discussed
below), to
facilitate recognition by an enzyme (e.g., a suitable ligase), to facilitate
identification, or
the like.
As mentioned, in certain aspects of the invention, one or more conditions may
be
encoded using such tags, e.g., added to droplets or other entities exposed to
such
conditions. Thus, for example, a droplet may be exposed to a first condition
and a first
tag added to the droplet, then the droplet may be exposed to a second
condition and a
second tag added to the droplet, then the droplet may be exposed to a third
condition and
a third tag added to the droplet, then the droplet may be exposed to a fourth
condition
and a fourth tag added to the droplet, etc. Accordingly, any number of
conditions may
be present, e.g., the droplet or other entity may be exposed to 2 3, 4, 5, 6,
7, 8, 9, 10, or
more conditions. The tags may also be combined together (e.g., ligated
together) to
CA 02945794 2016-10-13
WO 2015/161177 PCT/US2015/026338
- 11 -
produce a joined tag that encodes the history and/or identity of the droplet
or entity, as
previously discussed.
Any suitable conditions may be encoded by the tags. For example, in one set of
embodiments, the identity of the droplet or other entity may be encoded using
one or
more tags. For example, each droplet or entity may be assigned a unique tag,
or a unique
combination of tags. As another example, the condition may be a species that a
droplet
or other entity is exposed to, internally and/or externally. Any of a wide
variety of
species may be encoded by a suitable tag. For example, the species may be a
drug (or a
suspected drug), a cell, a polymer, a peptide, a protein, an enzyme, a
hormone, an
antibiotic, a vitamin, a carbohydrate, a sugar, an antibody, a reagent, a gas,
a dye, an ion,
a virus, a bacterium, pH level (e.g., acidic or basic conditions), or the
like. Thus, for
example, a plurality of cells, or a plurality of cell types may be encoded
using a unique
tag, or a unique combination of tags. Any number of tags may be used to encode
such
conditions, depending on the application. For example, there may be at least
10, at least
30, at least 50, at least 100, at least 300, at least 500, at least 1,000, at
least 3,000, at least
5,000, at least 10,000, at least 30,000, at least 50,000, at least 100,000, or
more unique
tags, e.g., substantially encoding a like number of suitable conditions such
as any of
those described herein. For instance, as a first condition, a library of
droplets, containing
a plurality of cells or cell types, may be encoded such that substantially
each droplet
contains one cell or one cell type, and an associated tag, such as a nucleic
acid.
In addition, the condition may also be an external physical condition in some
instances. For example, the droplet or other entity may be exposed to an
external
physical condition such as a certain or predetermined temperature, pressure,
electrical
condition (e.g., current, voltage, etc.), etc. and a suitable tag may be
introduced into the
droplet or entity before, during, or after exposure to the external physical
condition. As
yet another example, the condition may be a processing condition, for example,
filtration, sedimentation, centrifugation, etc.
In one set of embodiments, the condition may be a condition used to lyse cells
that may be contained within the droplets. For example, the condition could be
exposure
to a lysing chemical (e.g., pure water, a surfactant such as Triton-X or SDS,
an enzyme
such as lysozyme, lysostaphin, zymolase, cellulase, mutanolysin, glycanases,
proteases,
mannase, etc.), or a physical condition (e.g., ultrasound, ultraviolet light,
mechanical
CA 02945794 2016-10-13
WO 2015/161177 PCT/US2015/026338
- 12 -
agitation, etc.). In some cases, lysing a cell will cause the cell to release
its contents,
e.g., cellular nucleic acids, proteins, enzymes, sugars, etc. In some
embodiments some
of the cellular nucleic acids may also be ligated to one or more nucleic acids
contained
within the droplet. For example, in one set of embodiments, RNA transcripts
typically
produced within the cells may be released and then ligated to the nucleic acid
tags.
Combinations of any of these and/or other conditions are also contemplated.
For
example, as noted above, a droplet may be exposed to a first condition encoded
by a first
tag, a second condition encoded by a second tag, a third condition encoded by
a third tag,
etc. The conditions may be the same or different. In addition, a droplet or
other entity
may be exposed to any number of conditions (e.g. 1, 2, 3, 4, 5, 6, etc.), and
different
droplets or entities need not be exposed to the same conditions, or the same
number of
conditions. In addition, in some embodiments, a plurality of droplets (or
other entities)
may be randomly exposed to a plurality of conditions, e.g., such that not all
droplets are
exposed to all conditions. As noted above, when a droplet or other entity is
exposed to a
condition, a nucleic acid encoding the condition may be added to the droplet
or entity,
such that the specific history of the droplet or entity need not be
predetermined, and can
be randomly determined. For instance, a plurality of initial, substantially
identical
droplets (or other entities) may be exposed to a plurality of second droplets
containing
different species (and/or one or more species at different concentrations),
such that each
initial droplet is randomly fused to one or more second droplets.
In addition, in some embodiments, droplets or other entities may be separated
or
sorted into various groups depending on various properties, and the tags
within each
group may be manipulated together and/or used to identify such droplet or
entities
having such properties. Thus, as non-limiting examples, a droplet (or other
entity) may
be sorted into a first group or a second group depending on whether a reaction
occurred
within the droplet or not, the droplet may be sorted based on a property of a
cell or other
species contained within the droplet, etc. The sorting may also occur into two
or more
groups.
In some cases, some or all of the groups of droplets (or other entities) may
be
analyzed, e.g., using the tags contained therein, to determine characteristics
of the
droplets or entities within those groups, and/or to determine characteristics
of the
droplets or entities within a group that separates that group from other
groups. For
CA 02945794 2016-10-13
WO 2015/161177 PCT/US2015/026338
- 13 -
instance, members of a group may have, in common, one or more tags, and/or one
or
more specific combinations of tags, that separates those group members from
other
group members, e.g., as was explained above with respect to Fig. 1C. Such tags
may be
used, for example, to identify or distinguish one or more conditions that
result in a
particular outcome from conditions that do not result in that outcome.
Thus, in one set of embodiments, a property of a droplet or other entity is
determined, and the droplet or other entity is sorted based on that property.
The property
may also be a property of a species contained within the droplet or entity,
such as a cell.
The property may be any physical or chemical property that can be determined.
For
instance, properties such as fluorescence, transparency, density, size,
volume, etc., of a
droplet or other entity (or species contained therein) may be determined, and
used for
sorting purposes. In some cases, one or more reagents may also be added to the
droplets
or other entities, e.g., to start or facilitate a reaction that can be
determined, e.g., for
sorting purposes.
In some cases, the droplets or other entities may be burst or disrupted in
order to
access the tags. This may occur at any suitable time, e.g., before or after
ligation or
joining of the tags together. For example, droplets contained in a carrying
fluid may be
disrupted using techniques such as mechanical disruption or ultrasound.
Similarly,
entities on a surface may be disrupted using exposure to chemical agents or
surfactants,
or washed or rinsed to collect the tags.
The tags may then be determined to determine the identity and/or history of
the
droplet (or other entity), e.g., to determine conditions that the droplet or
other entity was
exposed to. Any suitable method can be used to determine the tags, depending
on the
type of tags used. For example, fluorescent particles may be determined using
fluorescence measurements, or nucleic acids may be sequenced using a variety
of
techniques and instruments, many of which are readily available commercially.
Examples of such techniques include, but are not limited to, chain-termination
sequencing, sequencing-by-hybridization, Maxam¨Gilbert sequencing, dye-
terminator
sequencing, chain-termination methods, Massively Parallel Signature Sequencing
(Lynx
Therapeutics), polony sequencing, pyrosequencing, sequencing by ligation, ion
semiconductor sequencing, DNA nanoball sequencing, single-molecule real-time
CA 02945794 2016-10-13
WO 2015/161177 PCT/US2015/026338
- 14 -
sequencing, nanopore sequencing, microfluidic Sanger sequencing, digital RNA
sequencing ("digital RNA-seq"), etc.
In addition, in some cases, one or more other species may be associated with
the
tags, e.g., covalently bound or ligated thereto. For example, as previously
discussed, in
some cases, nucleic acids released by a lysed cell may be ligated to one or
more tags.
These may include, for example, chromosomal DNA, RNA transcripts, tRNA, mRNA,
mitochondrial DNA, or the like. Such nucleic acids may be sequenced, in
addition to
sequencing the tags themselves, which may yield information about the nucleic
acid
profile of the cells, which can be associated with the tags, or the conditions
that the
corresponding droplet or cell was exposed to. Thus, as a non-limiting example,
RNA
transcripts from the cell may be ligated to one or more tags, which may be
sequenced
and correlated with conditions that the corresponding droplet or cell to
determine
information such as apoptosis gene signatures, growth arrest signatures,
immune
signatures, metabolic gene sets, or expression of genes that confer
susceptibility or
resistance to other known agents, etc.
Tags such as those described herein may be used in a variety of situations,
for
example, to screen or bioprospect for new drugs or other treatments, as a high-
throughput screening technique, to study the effect various exposure
conditions have on
cells, or the like. In addition, it should be understood that the invention is
not limited to
only cell studies. For example, a chemical contained within a droplet may be
exposed to
a variety of different conditions (e.g., potential reactants or catalysts,
reaction conditions,
initiators, etc.) and the different conditions tagged for determining or
optimizing the
reactions that the chemical is able to participate in. In some cases, the
chemical may be a
biologically active chemical (e.g., a drug, a protein, a polymer, a
carbohydrate, etc.),
although in other cases, the chemical need not be biologically relevant. For
example, the
chemical may be a monomer or a polymer, a catalyst, a semiconductor material,
etc.
As a non-limiting example, in one set of embodiments, a plurality of
substantially
identical cells can be exposed to a variety of substances (e.g., other cells,
chemical
compounds, soil samples, naturally-occurring samples, etc.), optionally under
various
physical conditions (e.g., various temperatures), to determine whether any of
the
substances have a beneficial or a detrimental effect on the cells. For
example, the
substantially identical cells may be cancer cells that are screened against a
panel of
CA 02945794 2016-10-13
WO 2015/161177 PCT/US2015/026338
- 15 -
substances to identify those substances that, alone or in combination, have
anti-cancer or
anti-tumor properties, or the substantially identical cells may be immune or
other cells to
which a certain activity is desired. The panel may include, for example,
naturally-
occurring compounds, synthetic compounds, compounds from a library, compounds
sharing certain properties, etc. In some cases, the compounds may also be
present at
more than one concentration. Each member of the panel may be tagged as
discussed
herein, such that, upon exposure of a cell in a droplet (or other entity) to a
panel member,
an appropriate corresponding tag is added. The tags may also be ligated or
otherwise
joined together. Thus, for example, the substantially identical cells may be
exposed to a
variety of substances, in various combinations, with subsequent sorting of
live cells from
dead cells; the tags from the droplets containing the live cells (and/or the
dead cells) may
be separated and sequenced as discussed herein to determine those conditions
or panel
members which were able to kill the cells. In addition, the invention is not
limited to
only substantially identical cells. For example, in another set of
embodiments, droplets
containing different cells (or other species, e.g., chemicals) may be used.
Additional details regarding systems and methods for manipulating droplets in
a
microfluidic system follow, e.g., for determining droplets (or species within
droplets),
sorting droplets, etc. For example, various systems and methods for screening
and/or
sorting droplets are described in U.S. Patent Application Serial No.
11/360,845, filed
February 23, 2006, entitled "Electronic Control of Fluidic Species," by Link,
et al.,
published as U.S. Patent Application Publication No. 2007/000342 on January 4,
2007,
incorporated herein by reference. As a non-limiting example, by applying (or
removing)
a first electric field (or a portion thereof), a droplet may be directed to a
first region or
channel; by applying (or removing) a second electric field to the device (or a
portion
thereof), the droplet may be directed to a second region or channel; by
applying a third
electric field to the device (or a portion thereof), the droplet may be
directed to a third
region or channel; etc., where the electric fields may differ in some way, for
example, in
intensity, direction, frequency, duration, etc.
In certain embodiments of the invention, sensors are provided that can sense
and/or determine one or more characteristics of the fluidic droplets, and/or a
characteristic of a portion of the fluidic system containing the fluidic
droplet (e.g., the
liquid surrounding the fluidic droplet) in such a manner as to allow the
determination of
CA 02945794 2016-10-13
WO 2015/161177 PCT/US2015/026338
- 16 -
one or more characteristics of the fluidic droplets. Characteristics
determinable with
respect to the droplet and usable in the invention can be identified by those
of ordinary
skill in the art. Non-limiting examples of such characteristics include
fluorescence,
spectroscopy (e.g., optical, infrared, ultraviolet, etc.), radioactivity,
mass, volume,
density, temperature, viscosity, pH, concentration of a substance, such as a
biological
substance (e.g., a protein, a nucleic acid, etc.), or the like.
In some cases, the sensor may be connected to a processor, which in turn,
cause
an operation to be performed on the fluidic droplet, for example, by sorting
the droplet,
adding or removing electric charge from the droplet, fusing the droplet with
another
droplet, splitting the droplet, causing mixing to occur within the droplet,
etc., for
example, as previously described. For instance, in response to a sensor
measurement of
a fluidic droplet, a processor may cause the fluidic droplet to be split,
merged with a
second fluidic droplet, etc.
One or more sensors and/or processors may be positioned to be in sensing
communication with the fluidic droplet. "Sensing communication," as used
herein,
means that the sensor may be positioned anywhere such that the fluidic droplet
within
the fluidic system (e.g., within a channel), and/or a portion of the fluidic
system
containing the fluidic droplet may be sensed and/or determined in some
fashion. For
example, the sensor may be in sensing communication with the fluidic droplet
and/or the
portion of the fluidic system containing the fluidic droplet fluidly,
optically or visually,
thermally, pneumatically, electronically, or the like. The sensor can be
positioned
proximate the fluidic system, for example, embedded within or integrally
connected to a
wall of a channel, or positioned separately from the fluidic system but with
physical,
electrical, and/or optical communication with the fluidic system so as to be
able to sense
and/or determine the fluidic droplet and/or a portion of the fluidic system
containing the
fluidic droplet (e.g., a channel or a microchannel, a liquid containing the
fluidic droplet,
etc.). For example, a sensor may be free of any physical connection with a
channel
containing a droplet, but may be positioned so as to detect electromagnetic
radiation
arising from the droplet or the fluidic system, such as infrared, ultraviolet,
or visible
light. The electromagnetic radiation may be produced by the droplet, and/or
may arise
from other portions of the fluidic system (or externally of the fluidic
system) and interact
with the fluidic droplet and/or the portion of the fluidic system containing
the fluidic
CA 02945794 2016-10-13
WO 2015/161177 PCT/US2015/026338
- 17 -
droplet in such as a manner as to indicate one or more characteristics of the
fluidic
droplet, for example, through absorption, reflection, diffraction, refraction,
fluorescence,
phosphorescence, changes in polarity, phase changes, changes with respect to
time, etc.
As an example, a laser may be directed towards the fluidic droplet and/or the
liquid
surrounding the fluidic droplet, and the fluorescence of the fluidic droplet
and/or the
surrounding liquid may be determined. "Sensing communication," as used herein
may
also be direct or indirect. As an example, light from the fluidic droplet may
be directed
to a sensor, or directed first through a fiber optic system, a waveguide,
etc., before being
directed to a sensor.
Non-limiting examples of sensors useful in the invention include optical or
electromagnetically-based systems. For example, the sensor may be a
fluorescence
sensor (e.g., stimulated by a laser), a microscopy system (which may include a
camera or
other recording device), or the like. As another example, the sensor may be an
electronic
sensor, e.g., a sensor able to determine an electric field or other electrical
characteristic.
For example, the sensor may detect capacitance, inductance, etc., of a fluidic
droplet
and/or the portion of the fluidic system containing the fluidic droplet.
As used herein, a "processor" or a "microprocessor" is any component or device
able to receive a signal from one or more sensors, store the signal, and/or
direct one or
more responses (e.g., as described above), for example, by using a
mathematical formula
or an electronic or computational circuit. The signal may be any suitable
signal
indicative of the environmental factor determined by the sensor, for example a
pneumatic
signal, an electronic signal, an optical signal, a mechanical signal, etc.
In one set of embodiments, a fluidic droplet may be directed by creating an
electric charge and/or an electric dipole on the droplet, and steering the
droplet using an
applied electric field, which may be an AC field, a DC field, etc. As an
example, an
electric field may be selectively applied and removed (or a different electric
field may be
applied, e.g., a reversed electric field) as needed to direct the fluidic
droplet to a
particular region. The electric field may be selectively applied and removed
as needed,
in some embodiments, without substantially altering the flow of the liquid
containing the
fluidic droplet. For example, a liquid may flow on a substantially steady-
state basis (i.e.,
the average flowrate of the liquid containing the fluidic droplet deviates by
less than 20%
or less than 15% of the steady-state flow or the expected value of the flow of
liquid with
CA 02945794 2016-10-13
WO 2015/161177 PCT/US2015/026338
- 18 -
respect to time, and in some cases, the average flowrate may deviate less than
10% or
less than 5%) or other predetermined basis through a fluidic system of the
invention
(e.g., through a channel or a microchannel), and fluidic droplets contained
within the
liquid may be directed to various regions, e.g., using an electric field,
without
substantially altering the flow of the liquid through the fluidic system.
In some embodiments, the fluidic droplets may be screened or sorted within a
fluidic system of the invention by altering the flow of the liquid containing
the droplets.
For instance, in one set of embodiments, a fluidic droplet may be steered or
sorted by
directing the liquid surrounding the fluidic droplet into a first channel, a
second channel,
etc.
In another set of embodiments, pressure within a fluidic system, for example,
within different channels or within different portions of a channel, can be
controlled to
direct the flow of fluidic droplets. For example, a droplet can be directed
toward a
channel junction including multiple options for further direction of flow
(e.g., directed
toward a branch, or fork, in a channel defining optional downstream flow
channels).
Pressure within one or more of the optional downstream flow channels can be
controlled
to direct the droplet selectively into one of the channels, and changes in
pressure can be
effected on the order of the time required for successive droplets to reach
the junction,
such that the downstream flow path of each successive droplet can be
independently
controlled. In one arrangement, the expansion and/or contraction of liquid
reservoirs
may be used to steer or sort a fluidic droplet into a channel, e.g., by
causing directed
movement of the liquid containing the fluidic droplet. The liquid reservoirs
may be
positioned such that, when activated, the movement of liquid caused by the
activated
reservoirs causes the liquid to flow in a preferred direction, carrying the
fluidic droplet in
that preferred direction. For instance, the expansion of a liquid reservoir
may cause a
flow of liquid towards the reservoir, while the contraction of a liquid
reservoir may cause
a flow of liquid away from the reservoir. In some cases, the expansion and/or
contraction of the liquid reservoir may be combined with other flow-
controlling devices
and methods, e.g., as described herein. Non-limiting examples of devices able
to cause
the expansion and/or contraction of a liquid reservoir include pistons and
piezoelectric
components. In some cases, piezoelectric components may be particularly useful
due to
CA 02945794 2016-10-13
WO 2015/161177 PCT/US2015/026338
- 19 -
their relatively rapid response times, e.g., in response to an electrical
signal. In some
embodiments, the fluidic droplets may be sorted into more than two channels.
As mentioned, certain embodiments are generally directed to systems and
methods for sorting fluidic droplets in a liquid, and in some cases, at
relatively high
rates. For example, a property of a droplet may be sensed and/or determined in
some
fashion (e.g., as further described herein), then the droplet may be directed
towards a
particular region of the device, such as a microfluidic channel, for example,
for sorting
purposes. In some cases, high sorting speeds may be achievable using certain
systems
and methods of the invention. For instance, at least about 10 droplets per
second may be
determined and/or sorted in some cases, and in other cases, at least about 20
droplets per
second, at least about 30 droplets per second, at least about 100 droplets per
second, at
least about 200 droplets per second, at least about 300 droplets per second,
at least about
500 droplets per second, at least about 750 droplets per second, at least
about 1,000
droplets per second, at least about 1,500 droplets per second, at least about
2,000
droplets per second, at least about 3,000 droplets per second, at least about
5,000
droplets per second, at least about 7,500 droplets per second, at least about
10,000
droplets per second, at least about 15,000 droplets per second, at least about
20,000
droplets per second, at least about 30,000 droplets per second, at least about
50,000
droplets per second, at least about 75,000 droplets per second, at least about
100,000
droplets per second, at least about 150,000 droplets per second, at least
about 200,000
droplets per second, at least about 300,000 droplets per second, at least
about 500,000
droplets per second, at least about 750,000 droplets per second, at least
about 1,000,000
droplets per second, at least about 1,500,000 droplets per second, at least
about
2,000,000 or more droplets per second, or at least about 3,000,000 or more
droplets per
second may be determined and/or sorted.
In some aspects, a population of relatively small droplets may be used. In
certain
embodiments, as non-limiting examples, the average diameter of the droplets
may be less
than about 1 mm, less than about 500 micrometers, less than about 300
micrometers,
less than about 200 micrometers, less than about 100 micrometers, less than
about 75
micrometers, less than about 50 micrometers, less than about 30 micrometers,
less than
about 25 micrometers, less than about 20 micrometers, less than about 15
micrometers,
less than about 10 micrometers, less than about 5 micrometers, less than about
3
CA 02945794 2016-10-13
WO 2015/161177 PCT/US2015/026338
- 20 -
micrometers, less than about 2 micrometers, less than about 1 micrometer, less
than
about 500 nm, less than about 300 nm, less than about 100 nm, or less than
about 50 nm.
The average diameter of the droplets may also be at least about 30 nm, at
least about 50
nm, at least about 100 nm, at least about 300 nm, at least about 500 nm, at
least about 1
micrometer, at least about 2 micrometers, at least about 3 micrometers, at
least about 5
micrometers, at least about 10 micrometers, at least about 15 micrometers, or
at least
about 20 micrometers in certain cases. The "average diameter" of a population
of
droplets is the arithmetic average of the diameters of the droplets.
In some embodiments, the droplets may be of substantially the same shape
and/or
size (i.e., "monodisperse"), or of different shapes and/or sizes, depending on
the
particular application. In some cases, the droplets may have a homogenous
distribution
of cross-sectional diameters, i.e., the droplets may have a distribution of
diameters such
that no more than about 5%, no more than about 2%, or no more than about 1% of
the
droplets have a diameter less than about 90% (or less than about 95%, or less
than about
99%) and/or greater than about 110% (or greater than about 105%, or greater
than about
101%) of the overall average diameter of the plurality of droplets. Some
techniques for
producing homogenous distributions of cross-sectional diameters of droplets
are
disclosed in International Patent Application No. PCT/US2004/010903, filed
April 9,
2004, entitled "Formation and Control of Fluidic Species," by Link et al.,
published as
WO 2004/091763 on October 28, 2004, incorporated herein by reference.
Those of ordinary skill in the art will be able to determine the average
diameter of
a population of droplets, for example, using laser light scattering or other
known
techniques. The droplets so formed can be spherical, or non-spherical in
certain cases.
The diameter of a droplet, in a non-spherical droplet, may be taken as the
diameter of a
perfect mathematical sphere having the same volume as the non-spherical
droplet.
In some embodiments, one or more droplets may be created within a channel by
creating an electric charge on a fluid surrounded by a liquid, which may cause
the fluid
to separate into individual droplets within the liquid. In some embodiments,
an electric
field may be applied to the fluid to cause droplet formation to occur. The
fluid can be
present as a series of individual charged and/or electrically inducible
droplets within the
liquid. Electric charge may be created in the fluid within the liquid using
any suitable
technique, for example, by placing the fluid within an electric field (which
may be AC,
CA 02945794 2016-10-13
WO 2015/161177 PCT/US2015/026338
- 21 -
DC, etc.), and/or causing a reaction to occur that causes the fluid to have an
electric
charge.
The electric field, in some embodiments, is generated from an electric field
generator, i.e., a device or system able to create an electric field that can
be applied to the
fluid. The electric field generator may produce an AC field (i.e., one that
varies
periodically with respect to time, for example, sinusoidally, sawtooth,
square, etc.), a DC
field (i.e., one that is constant with respect to time), a pulsed field, etc.
Techniques for
producing a suitable electric field (which may be AC, DC, etc.) are known to
those of
ordinary skill in the art. For example, in one embodiment, an electric field
is produced
by applying voltage across a pair of electrodes, which may be positioned
proximate a
channel such that at least a portion of the electric field interacts with the
channel. The
electrodes can be fashioned from any suitable electrode material or materials
known to
those of ordinary skill in the art, including, but not limited to, silver,
gold, copper,
carbon, platinum, copper, tungsten, tin, cadmium, nickel, indium tin oxide
("ITO"), etc.,
as well as combinations thereof.
In another set of embodiments, droplets of fluid can be created from a fluid
surrounded by a liquid within a channel by altering the channel dimensions in
a manner
that is able to induce the fluid to form individual droplets. The channel may,
for
example, be a channel that expands relative to the direction of flow, e.g.,
such that the
fluid does not adhere to the channel walls and forms individual droplets
instead, or a
channel that narrows relative to the direction of flow, e.g., such that the
fluid is forced to
coalesce into individual droplets. In some cases, the channel dimensions may
be altered
with respect to time (for example, mechanically or electromechanically,
pneumatically,
etc.) in such a manner as to cause the formation of individual droplets to
occur. For
example, the channel may be mechanically contracted ("squeezed") to cause
droplet
formation, or a fluid stream may be mechanically disrupted to cause droplet
formation,
for example, through the use of moving baffles, rotating blades, or the like.
Certain embodiments are generally directed to systems and methods for
splitting
a droplet into two or more droplets. For example, a droplet can be split using
an applied
electric field. The droplet may have a greater electrical conductivity than
the
surrounding liquid, and, in some cases, the droplet may be neutrally charged.
In certain
embodiments, in an applied electric field, electric charge may be urged to
migrate from
CA 02945794 2016-10-13
WO 2015/161177 PCT/US2015/026338
- 22 -
the interior of the droplet to the surface to be distributed thereon, which
may thereby
cancel the electric field experienced in the interior of the droplet. In some
embodiments,
the electric charge on the surface of the droplet may also experience a force
due to the
applied electric field, which causes charges having opposite polarities to
migrate in
opposite directions. The charge migration may, in some cases, cause the drop
to be
pulled apart into two separate droplets.
Some embodiments of the invention generally relate to systems and methods for
fusing or coalescing two or more droplets into one droplet, e.g., where the
two or more
droplets ordinarily are unable to fuse or coalesce, for example, due to
composition,
surface tension, droplet size, the presence or absence of surfactants, etc. In
certain cases,
the surface tension of the droplets, relative to the size of the droplets, may
also prevent
fusion or coalescence of the droplets from occurring.
As a non-limiting example, two droplets can be given opposite electric charges
(i.e., positive and negative charges, not necessarily of the same magnitude),
which can
increase the electrical interaction of the two droplets such that fusion or
coalescence of
the droplets can occur due to their opposite electric charges. For instance,
an electric
field may be applied to the droplets, the droplets may be passed through a
capacitor, a
chemical reaction may cause the droplets to become charged, etc. The droplets,
in some
cases, may not be able to fuse even if a surfactant is applied to lower the
surface tension
of the droplets. However, if the droplets are electrically charged with
opposite charges
(which can be, but are not necessarily of, the same magnitude), the droplets
may be able
to fuse or coalesce. As another example, the droplets may not necessarily be
given
opposite electric charges (and, in some cases, may not be given any electric
charge), and
are fused through the use of dipoles induced in the droplets that causes the
droplets to
coalesce. Also, the two or more droplets allowed to coalesce are not
necessarily required
to meet "head-on." Any angle of contact, so long as at least some fusion of
the droplets
initially occurs, is sufficient. See also, e.g., U.S. Patent Application
Serial No.
11/698,298, filed January 24, 2007, entitled "Fluidic Droplet Coalescence," by
Ahn, et
al., published as U.S. Patent Application Publication No. 2007/0195127 on
August 23,
2007, incorporated herein by reference in its entirety.
In one set of embodiments, a fluid may be injected into a droplet. The fluid
may
be microinjected into the droplet in some cases, e.g., using a microneedle or
other such
CA 02945794 2016-10-13
WO 2015/161177 PCT/US2015/026338
- 23 -
device. In other cases, the fluid may be injected directly into a droplet
using a fluidic
channel as the droplet comes into contact with the fluidic channel. Other
techniques of
fluid injection are disclosed in, e.g., International Patent Application No.
PCT/US2010/040006, filed June 25, 2010, entitled "Fluid Injection," by Weitz,
et al.,
published as WO 2010/151776 on December 29, 2010; or International Patent
Application No. PCT/US2009/006649, filed December 18, 2009, entitled "Particle-
Assisted Nucleic Acid Sequencing," by Weitz, et al., published as WO
2010/080134 on
July 15, 2010, each incorporated herein by reference in its entirety.
A variety of materials and methods, according to certain aspects of the
invention,
can be used to form articles or components such as those described herein,
e.g., channels
such as microfluidic channels, chambers, etc. For example, various articles or
components can be formed from solid materials, in which the channels can be
formed via
micromachining, film deposition processes such as spin coating and chemical
vapor
deposition, laser fabrication, photolithographic techniques, etching methods
including
wet chemical or plasma processes, and the like. See, for example, Scientific
American,
248:44-55, 1983 (Angell, et al).
In one set of embodiments, various structures or components of the articles
described herein can be formed of a polymer, for example, an elastomeric
polymer such
as polydimethylsiloxane ("PDMS"), polytetrafluoroethylene ("PTFE" or Teflon ),
or the
like. For instance, according to one embodiment, a microfluidic channel may be
implemented by fabricating the fluidic system separately using PDMS or other
soft
lithography techniques (details of soft lithography techniques suitable for
this
embodiment are discussed in the references entitled "Soft Lithography," by
Younan Xia
and George M. Whitesides, published in the Annual Review of Material Science,
1998,
Vol. 28, pages 153-184, and "Soft Lithography in Biology and Biochemistry," by
George M. Whitesides, Emanuele Ostuni, Shuichi Takayama, Xingyu Jiang and
Donald
E. Ingber, published in the Annual Review of Biomedical Engineering, 2001,
Vol. 3,
pages 335-373; each of these references is incorporated herein by reference).
Other examples of potentially suitable polymers include, but are not limited
to,
polyethylene terephthalate (PET), polyacrylate, polymethacrylate,
polycarbonate,
polystyrene, polyethylene, polypropylene, polyvinylchloride, cyclic olefin
copolymer
(COC), polytetrafluoroethylene, a fluorinated polymer, a silicone such as
CA 02945794 2016-10-13
WO 2015/161177 PCT/US2015/026338
- 24 -
polydimethylsiloxane, polyvinylidene chloride, bis-benzocyclobutene ("BCB"), a
polyimide, a fluorinated derivative of a polyimide, or the like. Combinations,
copolymers, or blends involving polymers including those described above are
also
envisioned. The device may also be formed from composite materials, for
example, a
composite of a polymer and a semiconductor material.
In some embodiments, various structures or components of the article are
fabricated from polymeric and/or flexible and/or elastomeric materials, and
can be
conveniently formed of a hardenable fluid, facilitating fabrication via
molding (e.g.
replica molding, injection molding, cast molding, etc.). The hardenable fluid
can be
essentially any fluid that can be induced to solidify, or that spontaneously
solidifies, into
a solid capable of containing and/or transporting fluids contemplated for use
in and with
the fluidic network. In one embodiment, the hardenable fluid comprises a
polymeric
liquid or a liquid polymeric precursor (i.e. a "prepolymer"). Suitable
polymeric liquids
can include, for example, thermoplastic polymers, thermoset polymers, waxes,
metals, or
mixtures or composites thereof heated above their melting point. As another
example, a
suitable polymeric liquid may include a solution of one or more polymers in a
suitable
solvent, which solution forms a solid polymeric material upon removal of the
solvent, for
example, by evaporation. Such polymeric materials, which can be solidified
from, for
example, a melt state or by solvent evaporation, are well known to those of
ordinary skill
in the art. A variety of polymeric materials, many of which are elastomeric,
are suitable,
and are also suitable for forming molds or mold masters, for embodiments where
one or
both of the mold masters is composed of an elastomeric material. A non-
limiting list of
examples of such polymers includes polymers of the general classes of silicone
polymers, epoxy polymers, and acrylate polymers. Epoxy polymers are
characterized by
the presence of a three-membered cyclic ether group commonly referred to as an
epoxy
group, 1,2-epoxide, or oxirane. For example, diglycidyl ethers of bisphenol A
can be
used, in addition to compounds based on aromatic amine, triazine, and
cycloaliphatic
backbones. Another example includes the well-known Novolac polymers. Non-
limiting
examples of silicone elastomers suitable for use according to the invention
include those
formed from precursors including the chlorosilanes such as
methylchlorosilanes,
ethylchlorosilanes, phenylchlorosilanes, dodecyltrichlorosilanes, etc.
CA 02945794 2016-10-13
WO 2015/161177 PCT/US2015/026338
- 25 -
Silicone polymers are used in certain embodiments, for example, the silicone
elastomer polydimethylsiloxane. Non-limiting examples of PDMS polymers include
those sold under the trademark Sylgard by Dow Chemical Co., Midland, MI, and
particularly Sylgard 182, Sylgard 184, and Sylgard 186. Silicone polymers
including
PDMS have several beneficial properties simplifying fabrication of various
structures of
the invention. For instance, such materials are inexpensive, readily
available, and can be
solidified from a prepolymeric liquid via curing with heat. For example, PDMSs
are
typically curable by exposure of the prepolymeric liquid to temperatures of
about, for
example, about 65 C to about 75 C for exposure times of, for example, about
an hour.
Also, silicone polymers, such as PDMS, can be elastomeric and thus may be
useful for
forming very small features with relatively high aspect ratios, necessary in
certain
embodiments of the invention. Flexible (e.g., elastomeric) molds or masters
can be
advantageous in this regard.
One advantage of forming structures such as microfluidic structures or
channels
from silicone polymers, such as PDMS, is the ability of such polymers to be
oxidized,
for example by exposure to an oxygen-containing plasma such as an air plasma,
so that
the oxidized structures contain, at their surface, chemical groups capable of
cross-linking
to other oxidized silicone polymer surfaces or to the oxidized surfaces of a
variety of
other polymeric and non-polymeric materials. Thus, structures can be
fabricated and
then oxidized and essentially irreversibly sealed to other silicone polymer
surfaces, or to
the surfaces of other substrates reactive with the oxidized silicone polymer
surfaces,
without the need for separate adhesives or other sealing means. In most cases,
sealing
can be completed simply by contacting an oxidized silicone surface to another
surface
without the need to apply auxiliary pressure to form the seal. That is, the
pre-oxidized
silicone surface acts as a contact adhesive against suitable mating surfaces.
Specifically,
in addition to being irreversibly sealable to itself, oxidized silicone such
as oxidized
PDMS can also be sealed irreversibly to a range of oxidized materials other
than itself
including, for example, glass, silicon, silicon oxide, quartz, silicon
nitride, polyethylene,
polystyrene, glassy carbon, and epoxy polymers, which have been oxidized in a
similar
fashion to the PDMS surface (for example, via exposure to an oxygen-containing
plasma). Oxidation and sealing methods useful in the context of the present
invention, as
well as overall molding techniques, are described in the art, for example, in
an article
CA 02945794 2016-10-13
WO 2015/161177 PCT/US2015/026338
- 26 -
entitled "Rapid Prototyping of Microfluidic Systems and Polydimethylsiloxane,"
Anal.
Chem., 70:474-480, 1998 (Duffy et al.), incorporated herein by reference.
Thus, in certain embodiments, the design and/or fabrication of the article may
be
relatively simple, e.g., by using relatively well-known soft lithography and
other
techniques such as those described herein. In addition, in some embodiments,
rapid
and/or customized design of the article is possible, for example, in terms of
geometry. In
one set of embodiments, the article may be produced to be disposable, for
example, in
embodiments where the article is used with substances that are radioactive,
toxic,
poisonous, reactive, biohazardous, etc., and/or where the profile of the
substance (e.g.,
the toxicology profile, the radioactivity profile, etc.) is unknown. Another
advantage to
forming channels or other structures (or interior, fluid-contacting surfaces)
from oxidized
silicone polymers is that these surfaces can be much more hydrophilic than the
surfaces
of typical elastomeric polymers (where a hydrophilic interior surface is
desired). Such
hydrophilic channel surfaces can thus be more easily filled and wetted with
aqueous
solutions than can structures comprised of typical, unoxidized elastomeric
polymers or
other hydrophobic materials.
The following documents are incorporated herein by reference in their entirety
for all purposes: Int. Pat. Apl. Pub. No. WO 2004/091763, entitled "Formation
and
Control of Fluidic Species," by Link et al.; Int. Pat. Apl. Pub. No. WO
2004/002627,
entitled "Method and Apparatus for Fluid Dispersion," by Stone et al.; Int.
Pat. Apl. Pub.
No. WO 2006/096571, entitled "Method and Apparatus for Forming Multiple
Emulsions," by Weitz et al.; Int. Pat. Apl. Pub. No. WO 2005/021151, entitled
"Electronic Control of Fluidic Species," by Link et al.; Int. Pat. Apl. Pub.
No. WO
2011/056546, entitled "Droplet Creation Techniques," by Weitz, et al.; Int.
Pat. Apl.
Pub. No. WO 2010/033200, entitled "Creation of Libraries of Droplets and
Related
Species," by Weitz, et al.; U.S. Pat. Apl. Pub. No. 2012-0132288, entitled
"Fluid
Injection," by Weitz, et al.; Int. Pat. Apl. Pub. No. WO 2008/109176, entitled
"Assay
And Other Reactions Involving Droplets," by Agresti, et al.; and Int. Pat.
Apl. Pub. No.
WO 2010/151776, entitled "Fluid Injection," by Weitz, et al.
Also incorporated herein by reference in its entirety is U.S. Provisional
Patent
Application Serial No. 61/981,123, filed April 17, 2014, entitled "Systems and
Methods
for Droplet Tagging," by Bernstein, et al.
CA 02945794 2016-10-13
WO 2015/161177 PCT/US2015/026338
- 27 -
While several embodiments of the present invention have been described and
illustrated herein, those of ordinary skill in the art will readily envision a
variety of other
means and/or structures for performing the functions and/or obtaining the
results and/or
one or more of the advantages described herein, and each of such variations
and/or
modifications is deemed to be within the scope of the present invention. More
generally,
those skilled in the art will readily appreciate that all parameters,
dimensions, materials,
and configurations described herein are meant to be exemplary and that the
actual
parameters, dimensions, materials, and/or configurations will depend upon the
specific
application or applications for which the teachings of the present invention
is/are used.
Those skilled in the art will recognize, or be able to ascertain using no more
than routine
experimentation, many equivalents to the specific embodiments of the invention
described herein. It is, therefore, to be understood that the foregoing
embodiments are
presented by way of example only and that, within the scope of the appended
claims and
equivalents thereto, the invention may be practiced otherwise than as
specifically
described and claimed. The present invention is directed to each individual
feature,
system, article, material, kit, and/or method described herein. In addition,
any
combination of two or more such features, systems, articles, materials, kits,
and/or
methods, if such features, systems, articles, materials, kits, and/or methods
are not
mutually inconsistent, is included within the scope of the present invention.
All definitions, as defined and used herein, should be understood to control
over
dictionary definitions, definitions in documents incorporated by reference,
and/or
ordinary meanings of the defined terms.
The indefinite articles "a" and "an," as used herein in the specification and
in the
claims, unless clearly indicated to the contrary, should be understood to mean
"at least
one."
The phrase "and/or," as used herein in the specification and in the claims,
should
be understood to mean "either or both" of the elements so conjoined, i.e.,
elements that
are conjunctively present in some cases and disjunctively present in other
cases.
Multiple elements listed with "and/or" should be construed in the same
fashion, i.e., "one
or more" of the elements so conjoined. Other elements may optionally be
present other
than the elements specifically identified by the "and/or" clause, whether
related or
unrelated to those elements specifically identified. Thus, as a non-limiting
example, a
CA 02945794 2016-10-13
WO 2015/161177 PCT/US2015/026338
- 28 -
reference to "A and/or B", when used in conjunction with open-ended language
such as
"comprising" can refer, in one embodiment, to A only (optionally including
elements
other than B); in another embodiment, to B only (optionally including elements
other
than A); in yet another embodiment, to both A and B (optionally including
other
elements); etc.
As used herein in the specification and in the claims, "or" should be
understood
to have the same meaning as "and/or" as defined above. For example, when
separating
items in a list, "or" or "and/or" shall be interpreted as being inclusive,
i.e., the inclusion
of at least one, but also including more than one, of a number or list of
elements, and,
optionally, additional unlisted items. Only terms clearly indicated to the
contrary, such
as "only one of" or "exactly one of," or, when used in the claims, "consisting
of," will
refer to the inclusion of exactly one element of a number or list of elements.
In general,
the term "or" as used herein shall only be interpreted as indicating exclusive
alternatives
(i.e. "one or the other but not both") when preceded by terms of exclusivity,
such as
"either," "one of," "only one of," or "exactly one of." "Consisting
essentially of," when
used in the claims, shall have its ordinary meaning as used in the field of
patent law.
As used herein in the specification and in the claims, the phrase "at least
one," in
reference to a list of one or more elements, should be understood to mean at
least one
element selected from any one or more of the elements in the list of elements,
but not
necessarily including at least one of each and every element specifically
listed within the
list of elements and not excluding any combinations of elements in the list of
elements.
This definition also allows that elements may optionally be present other than
the
elements specifically identified within the list of elements to which the
phrase "at least
one" refers, whether related or unrelated to those elements specifically
identified. Thus,
as a non-limiting example, "at least one of A and B" (or, equivalently, "at
least one of A
or B," or, equivalently "at least one of A and/or B") can refer, in one
embodiment, to at
least one, optionally including more than one, A, with no B present (and
optionally
including elements other than B); in another embodiment, to at least one,
optionally
including more than one, B, with no A present (and optionally including
elements other
than A); in yet another embodiment, to at least one, optionally including more
than one,
A, and at least one, optionally including more than one, B (and optionally
including other
elements); etc.
CA 02945794 2016-10-13
WO 2015/161177 PCT/US2015/026338
- 29 -
It should also be understood that, unless clearly indicated to the contrary,
in any
methods claimed herein that include more than one step or act, the order of
the steps or
acts of the method is not necessarily limited to the order in which the steps
or acts of the
method are recited.
In the claims, as well as in the specification above, all transitional phrases
such as
"comprising," "including," "carrying," "having," "containing," "involving,"
"holding,"
"composed of," and the like are to be understood to be open-ended, i.e., to
mean
including but not limited to. Only the transitional phrases "consisting of'
and
"consisting essentially of" shall be closed or semi-closed transitional
phrases,
respectively, as set forth in the United States Patent Office Manual of Patent
Examining
Procedures, Section 2111.03.
